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INTRODUCTION
The evolving field of laparoscopy in gynecologic surgery has 
enabled endoscopic management of most adnexal masses [1]. 
While laparoscopy has been widely accepted as a standard 
diagnostic and therapeutic method for adnexal masses 
that have a low risk of malignancy, several authors have 
questioned the use of this approach for malignant adnexal 
masses. Potential issues raised with the use of laparoscopy 
for adnexal masses include misdiagnosis, tumor spillage, and 
inability to perform a complete staging and/or debulking 
procedure [2]. 
Laparoscopy offers multiple advantages over the traditional 
laparotomy approach including smaller size of incisions, im­
proved visualization, decreased blood loss, and faster recovery. 
An additional controversial advantage for patients with an ova­
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rian malignancy that require adjuvant chemotherapy, is a 
shorter interval to the initiation of treatment [3].
The feasibility of laparoscopic management of benign 
adnexal masses has been previously described in many re­
ports [4,5]. However, there are only a few studies in the litera­
ture that describe the combined outcomes of a large number 
of patients with adnexal masses that are not specifically thou­
ght to be at a low risk for malignancy. In 1999 Dottino et al. [6], 
specifically reported an early 4 year experience of laparoscopic 
management of adnexal masses in patients that had both a 
low and high risk of malignancy at the Mount Sinai Hospital 
in New York. In our current study, we update the laparoscopic 
experience at Mount Sinai (10 years later), and report on the 
feasibility and complication rates in the laparoscopic manage­
ment of 694 women with benign and malignant adnexal 
masses in this institution. 
MATERIALS AND METHODS
This is a retrospective review of all women who underwent 
laparoscopic management of an adnexal mass at the Mount 
Sinai School of Medicine (New York, NY, USA) during the 
period of July 2004 to June 2008. This evaluation included 
all laparoscopic cases performed for adnexal pathology (uni­
lateral or bilateral), regardless of indication for surgery and 
preoperative level of suspicion for malignancy. Institutional 
Review Board approval was obtained. All patients in our study 
were managed surgically either by a gynecologic oncologist 
or general gynecologist attending physician from the Mount 
Sinai School of Medicine. Routine preoperative evaluation 
of the patients included history and physical examination, 
serum CA­125 and at least one imaging modality of the 
pelvic/abdominal cavity. Modalities included ultrasonography, 
computed tomography (CT) and/or magnetic resonance 
imaging (MRI). The radiology report for all imaging studies 
was carefully read and masses were considered to be 
suspicious for malignancy when there was presence of either 
multi­loculation, papillary projections, ascites and/or when 
an overall suspicion for malignancy was clearly stated by the 
radiologist.
After the appropriate preoperative evaluation was 
completed, each patient included in the study underwent 
laparoscopic management of the adnexal abnormality 
with the indicated procedures. The operations performed 
were included in the following categories: 1) ovarian 
cystectomy, 2) adnexectomy (salpingoophorectomy, 
oophorectomy, salpingectomy and/or resection of broad 
ligament myoma), 3) laparoscopic total hysterectomy±
unilateral or bilateral salpingo­oophorectomy (LH±SO), 
4) laparoscopic supracervical hysterectomy±unilateral or 
bilateral salpingo­oophorectomy (LSH±SO), 5) laparoscopic 
staging for malignancy (hysterectomy with bilateral salping­
oophorectomy±appendectomy, peritoneal washings 
peritoneal biopsies, omentectomy with pelvic and paraaortic 
lymph node dissection), and 6) other laparoscopic procedures. 
The laparoscopic management of an adnexal mass that was 
suspicious for malignancy included an attempt to remove the 
mass intact from the abdomen in a laparoscopic endobag 
with care to avoid rupture and/or spillage. Intraoperative 
specimen evaluation by the surgeon and/or pathology 
department (frozen section) was used to further guide the 
attending surgeon. Robotic surgeries were not included in the 
study. 
A computerized database was created recording the 
patient characteristics, preoperative workup, preoperative 
and postoperative diagnosis, intraoperative findings 
and impression, surgery performed, intraoperative and 
postoperative complications, estimated blood loss, operative 
time, duration of hospital stay, frozen section and final 
pathological diagnosis. The preoperative assessment was 
considered benign if the CA­125 determination was <35 U/mL 
(WNL) and the imaging study (ies) suggested the mass to be 
benign. For stratification purposes, if either the CA­125 was ≥ 
35 U/mL or any of the imaging studies suggested malignancy, 
the preoperative assessment was considered suspicious for 
malignancy. 
In order to evaluate laparoscopic outcome variables 
including cyst rupture, conversion rate, and complication 
rates, the patients were stratified into 3 groups based on 
a comparison of the preoperative assessment and final 
postoperative pathologic diagnosis. 
­ Group I (concordant benign): preoperative assessment 
benign and final pathology benign.
­ Group II (discordant): preoperative assessment benign and 
final pathology malignant or vice versa.
­ Group III (concordant malignant): preoperative assessment 
suspicious/malignant and final pathology malignant.
The statistical analysis was performed using the SPSS ver. 17 
(SPSS Inc., Chicago, IL, USA). Qualitative data was described by 
using unit number and percent; mean and standard deviation 
were used to describe the quantitative data. Student 
t­test and analysis of variance tests (ANOVA) were used to 
compare quantitative variables among two or more groups 
respectively. c
2 test was used to compare qualitative variables 
among groups.Mohamad S. Gad, et al.
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RESULTS
There were 694 women that underwent laparoscopic 
surgical management of an adnexal mass. Gynecologic 
oncologist (10/88 surgeons, 11.4%) attendings performed 
58.1% of the operations, and general gynecologists (78/88 
surgeons, 88.6%) performed 41.9% of the operations in the 
study. Descriptive characteristics are shown in Table 1. 
Complete laparoscopic management was successful in 
678 (97.7%) of cases and included 197 ovarian cystectomies 
(28.4%), 402 adnexectomies (58.1%), 37 LH±SO (5.3%), 10 
LSH±SO (1.4%), and 27 laparoscopic complete staging 
procedures for malignancy (3.8%). Six of these 27 patients had 
optimal cytoreduction for advanced stage carcinoma (0.8%). 
Five patients had other laparoscopic procedures such as 
adhesiolysis (0.7%). The average operative time was 1.6 hours 
(range, 0.3 to 7 hours), the average blood loss was 65 mL 
(range, 5 to 1,100 mL) and the average duration of hospital 
stay was 1.5 days (range, 1 to 12 days). 
There were a total of 13 intraoperative complications (1.9%) 
including 6 urinary tract injuries, 4 cases of bowel injury and 
3 cases of vascular injury. The intraoperative complications 
were managed laparoscopically in all but two cases. In one 
case, a small bowel injury was repaired through a laparotomy 
incision; a case of a bladder injury required a laparotomy to 
allow a partial cystectomy with ureteral reimplantation and 
tumor debulking for advanced malignant disease. 
Sixteen patients had postoperative complications (2.3%). One 
patient had a sigmoid colon enterotomy that was diagnosed 
postoperatively and was repaired by laparotomy; one patient 
had transient abdominal distention in which intestinal perfora­
tion was ruled out by a diagnostic laparoscopy; three patients 
with unspecified postoperative febrile morbidity (treated with 
broad spectrum antibiotics); three patients required a blood 
transfusion; three incisional hernias (one case of incarcerated 
hernia at the trocar site that was repaired laparoscopically and 
two cases that underwent a hernia repair by laparotomy in the 
year following surgery); one wound infection/abscess (treated 
with incision and drainage and broad spectrum antibiotics); 
one case of a rectovaginal fistula managed by laparoscopic 
loop ileostomy and vaginal fistula repair; and three cases of 
intestinal ileus, which resolved spontaneously.
Conversion to laparotomy was performed in 16 patients 
(2.3%), 8 cases due to extensive adhesions (prior laparotomies 
or endometriosis), 6 patients were converted secondary to 
advanced stage malignancy for tumor debulking, one case 
secondary to poor visualization due to megacolon and one 
due to small bowel injury. The average body mass index (BMI) 
of all patients included in the study was 28.2 and the BMI 
of the patients that were converted to laparotomy was 28.7 
(p=NS) and none of the patients converted had a BMI greater 
than 35. Of the 16 patients converted to laparotomy, 9 had 
no prior abdominal surgery, five had 1 prior operation, one 
patient had 2 prior operations and one had 4 prior abdominal 
surgical procedures.
Benign pathology was encountered in 635 (91.5%) patients. 
Ovarian cystadenoma (24.8%) and endometrioma (22%) were 
the most common pathologic diagnosis. Ovarian borderline 
tumors were diagnosed in 21 patients (2.9%) including 16 
with serous and 5 with mucinous histology. The International 
Federation of Gynecology and Obstetrics (FIGO) staging for 
the patients with borderline tumors was as follows: 18 stage I, 
1 stage II and 2 stage III patients. Thirteen of the 21 borderline 
tumors had unremarkable (unsuspicious for carcinoma) 
preoperative imaging (11 cases of unilateral simple cysts and 
2 cases of bilateral simple cysts) and all 13 were found to be 
stage I on final pathology. Eight patients had suspicious pre­
operative imaging (solid nodules ­3­, calcification of wall ­1­, 
thickened nodular cyst wall ­2­ or septae ­2­). Only 4 had pre­
operative CA­125 sent and all were elevated (>35 U/mL). 
Five of the 8 suspicious borderline tumors were found to 
be stage I on final pathology while 3 borderline cases were 
more advanced (one stage II and two stage III). Of the 21 
borderline tumors, 6 underwent initial cystectomy followed by 
additional operation at a later date. Five women underwent 
adnexectomy, and 10 had laparoscopic staging. No patient 
with a borderline ovarian tumor recurred during the follow­up 
period (range, 3 to 56 months). 
Malignant tumors were diagnosed in 38 women (5.6%). 
Table 1. Demographic characteristics (n=694)
Characteristics Mean±SD or no. (%)
Age (yr) 49.9±4.7
Nulliparous 266 (43.8)
Postmenopausal 276 (39.8)
No. of previous abdominal surgeries:
None 476 (68)
One 156 (22)
Two 24 (3.4)
Three or more 27 (3.7)
Positive family history of ovarian and/or 
breast cancer (1st degree relative)
107 (15.4)
Body mass index   28.2±4.8
<20 38 (5.5)
20-30 341 (49.1)
30-40 185 (26.7)
>40 12  (1.7)Perioperative outcomes after laparoscopic management of adnexal masses
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These included 35 ovarian malignancies, 1 fallopian tube 
carcinoma, and 2 non gynecologic malignancies which were 
found to not involve the ovaries at exploration (one peritoneal 
adenosarcoma and one leiomyosarcoma of the large 
intestine). Of the 35 patients who had an ovarian malignancy, 
32 were primary ovarian carcinoma and 3 were metastatic 
to the ovary (1 breast and 2 colon). The primary ovarian 
malignancies included 28 epithelial, 3 sex cord – stromal 
tumors and 1 ovarian sarcoma. 
Of the 32 primary ovarian carcinomas 11 were stage I (7 IA, 
4 IB, and 0 IC); seven of which were suspicious preoperatively 
by imaging. Stage II ovarian carcinoma was diagnosed in 7 
patients (1 IIA, 2 IIB, and 4 IIC); four of which were suspicious 
preoperatively by imaging. The remainder of cases of ovarian 
carcinoma were stage III or IV. 
The women were stratified into 3 groups based on the 
concordance of the preoperative assessment and final 
postoperative pathologic diagnosis, Group I (concordant 
benign, 584 pts), Group II (discordant, 76 pts) and Group 
III (concordant malignant, 34 pts). Laparoscopic outcome 
variables in the three groups are presented in (Table 2). The 
difference in the incidence of ovarian cyst rupture in Group 
I and II vs. Group III was statistically significant (I, 26%; II, 
22.1%; III, 3%; p<0.05). The difference in the percentage of 
conversion to laparotomy in Group III vs. Group I and II was 
statistically significant (I, 0.9%; II, 3.4%; III, 24.2%; p<0.001). 
Other differences that were statistically significant were blood 
loss, operative time and duration of hospital stay. There were 
no statistically significant differences in intraoperative and 
postoperative complications between the three groups.
An additional stratification of adnexal masses was made 
based on the final pathologic diagnosis: benign vs. borderline/
malignant (Table 3). The difference in incidence of ovarian 
cyst rupture in benign adnexal masses and borderline/
malignant tumors was statistically significant (26% vs. 8.7%, 
p­value<0.05). Patients with borderline/malignant adnexal 
masses had a statistically significant increase in the percentage 
of conversion to laparotomy in comparison to patients with 
benign pathology (0.9% vs. 16.9%, p­value<0.001). Other 
variables that were statistically different in both groups were 
blood loss, operative time and duration of hospital stay. 
Although the difference in the intraoperative complications 
between the 2 groups was not statistically significant, the 
patients with borderline/malignant tumors had statistically 
more postoperative complications than patients with benign 
pathology (1.9% vs. 12.2%, p­value <0.05).
Table 2. Comparison of laparoscopic outcome variables in the three groups
Variables Group I (n=584) Group II (n=76) Group III (n=34) Total (n=694) c
2 p-value
Ovarian cyst rupture 152 (26) 17 (22.4) 1 (3) 170 (24.5) 9.7 <0.05
Conversion to laparotomy 5 (0.9) 3 (3.9) 8 (23.5) 16 (2.3) 75.5 <0.001
Intraopertive complications 13 (2.2) 0 (0.0) 2(5.9) 15 (2.2) 3.8 >0.05
Postoperative complications 12 (2) 1 (1.3) 3 (8.8) 16 (2.3) 3.8 >0.05
Blood loss* (mL) 57.2±92.1 81.4±85.3 173.8±142.5 65.6±97.8 48.9 <0.001
Operative time* (hr) 1.0±0.9 1.9±1.3 3.4±1.6 1.6±1.1 56.5 <0.001
Hospital stay* (day) 1.4±1.2 2.0±2.0 3.0±2.0 1.5±1.3 69.5 <0.001
Values are presented as number (%) or mean±SD. *By Kruskal Wallis test.
Table 3. Comparison of laparoscopic outcome variables between benign adnexal masses and borderline/malignant adnexal masses
Benign adnexal masses 
(n=635)
Malignant and borderline 
adnexal masses (n=59) c
2 p-value
Ovarian cyst rupture 165 (26) 5 (8.6) 9.3 <0.05
Conversion to laparotomy 6 (0.9) 10 (16.9) 54.3 <0.001
Intraoperative complications 13 (2) 2 (3.3) 0.02 >0.05
Postoperative complications 12 (1.9) 4 (12.2) 5.8 <0.05
Blood loss* (mL) 58.5±91.2 139.7±129.8 6.3 <0.001
Operative time* (hr) 1.5±0.9 2.9±1.8 6.3 <0.001
Hospital stay* (day) 1.4±1.2 2.6±2.1 7.7 <0.001
Values are presented as number (%) or mean±SD. *By Mann-Whitney test.Mohamad S. Gad, et al.
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DISCUSSION
Historically, laparoscopy was predominantly used in 
gynecology for the management of benign appearing 
adnexal masses. Because of the larger cohort of experienced 
laparoscopic surgeons especially gynecologic oncologists, 
and the rapid and major technologic advancements including 
instrumentation and robotics, laparoscopy has been 
increasingly utilized for the management of malignant adnexal 
masses in the last decade [7]. Until recently, if the preoperative 
assessment of an adnexal mass was suspicious for malignancy, 
a surgical exploration via midline vertical abdominal incision 
was commonly mandated to allow comprehensive surgical 
staging and debulking. The contemporary algorithm for the 
diagnosis and treatment of benign and suspicious adnexal 
masses has transitioned to a laparoscopic approach in an 
effort to improve patient recovery and reduce the incidence 
of an unnecessary laparotomy [8,9].
Published opinion regarding the role of laparoscopic surgery 
in the management of an adnexal mass with moderate to 
high suspicion of malignancy is divided between those 
advocating its use [3,6,10] and those still mandating initial 
laparotomy [4,5]. Other surgeons offer a compromise, such 
as avoiding the use of laparoscopic management in all 
postmenopausal patients [11] or initiating laparoscopic 
assessment and then proceeding to laparotomy if the mass 
appears suspicious intraoperatively [12]. In a survey of the 
members of the American Association of Gynecologic 
Laparoscopists comprised mainly of general laparoscopists, 
12% of respondents stated that they would perform a 
laparoscopy on a woman with an adnexal mass that is 
suspicious for malignancy as their initial approach [13]. 
In our series, 10 of the surgeons were highly experienced 
gynecologic oncologists (10/88 surgeons included) and 
they performed 58.1% of the adnexal laparoscopic surgeries 
included in the study. Many previous studies included only 
a limited number of highly experienced oncologic surgeons 
[3,6]. The inclusion of all adnexal masses managed by both 
generalists and specialists offer a unique perspective to 
the analysis of this data. In our study, 91.5% of all adnexal 
masses were benign on final pathology. In other studies the 
incidence of unexpected cancers discovered at the time of 
laparoscopy for non suspicious adnexal masses has shown 
to be exceptionally low (0.6%) [4]. The higher incidence of 
borderline and malignant tumors reported when compared 
to previous studies is likely due to the fact that we included 
suspicious masses as well as the fact that 60% of the cases 
were managed by gynecologic oncologists with referral 
practices. 
There are many advantages of laparoscopic surgery reported 
in other studies including avoiding a laparotomy, shorter 
operative time, decreased blood loss, shorter hospital stay, 
and fewer complications. These findings were confirmed in 
our study. Our average blood loss was 65 mL and the average 
duration of hospital stay was 1.5 days. These findings suggest 
that laparoscopy has a low morbidity and can be safely used 
for the management of benign and malignant adnexal masses 
as previously described [3,10]. 
In our study, the conversion to laparotomy in patients 
with carcinoma or borderline tumors was comparable to a 
Gynecologic Oncology Group (GOG) study from 2005 [14]. 
In a study by Chi et al. [15] 2005, there were no conversions 
to laparotomy; this report however only included 20 stage I 
patients that were managed laparoscopically. It appears that 
patient selection, diagnosis, extent of disease, and skill of the 
operating surgeon play an important role in the reported 
conversion rates. We found that conversion to laparotomy 
was highest in patients with either advanced stage ovarian 
cancer, or metastatic non gynecological malignancy.
The available data for incidence of cyst rupture while 
performing laparoscopy or laparotomy for adnexal masses 
vary widely. Laparoscopic tumor rupture rates have been 
reported from 10.5% to 41.8% [16,17]. These rates may vary 
based on the planned procedure such as cystectomy versus 
adnexectomy [18]. Some studies imply a difference in rupture 
rates with laparoscopy compared with laparotomy, but other 
studies refute this difference. In our study, the incidence 
of cyst rupture in benign masses was consistent with the 
findings in previous reports [5] and in order to prevent spillage 
and up­staging of carcinomas, the preferred technique used 
in our Institution is to place an unruptured cyst/adnexa in an 
endoscopic bag and to aspirate its contents. This is followed 
by removal of the specimen through an adequate trocar site. 
The clinical significance of cyst rupture is also uncertain. 
Currently, the largest study addressing cyst rupture consists of 
a retrospective, multicenter study of more than 1,500 patients. 
A cyst or mass rupture was found to be an independent 
predictor of decreased disease­free survival [19]. In contrast, 
no survival difference existed among a retrospective review 
of 394 patients [20]. Other studies show that intraoperative 
rupture would up­stage malignant cysts and therefore 
necessitate the use of adjuvant chemotherapy for patients 
who may not otherwise have required it [21]. In our series, 
tumor spillage occurred in 1 case of ovarian sarcoma and in 
the case of peritoneal adenosarcoma not involving the ovary. 
In both these cases, tumor spillage did not affect staging or 
prognosis of the patients.
The risk of port site metastasis in laparoscopic cancer surgery Perioperative outcomes after laparoscopic management of adnexal masses
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was highlighted by some early case series that reported a 
range of 0% to 2.3% with an even higher incidence in patients 
with recurrent ovarian cancer or in the presence of ascites 
[22,23]. In our study, no cases of port site metastasis were 
reported after a mean follow up of 22.1 months.
Contrarily to postoperative complications, the incidence 
of intraoperative complications was similar in benign and 
malignant masses. Previous studies have reported various 
types of complications and morbidities associated with 
laparoscopy with a variable rate of 4­11% [15,24]. Opposite 
to some prior reports, we observed no major vascular injuries 
[19,25].
Laparoscopic management of suspicious adnexal masses 
is technically feasible with a low morbidity rate. In addition 
to sparing patients from unnecessary laparotomy, operative 
laparoscopy can be employed for complete surgical staging as 
previously shown [6,10]. In our series, the majority of patients 
with borderline tumors or ovarian cancer were successfully 
managed by laparoscopic optimal tumor cytoreduction and 
staging.
It is now accepted that laparoscopy offers many advantages 
over laparotomy for the management of benign adnexal 
masses at a low complication rate. Our study supports that 
the laparoscopic technique offers these same benefits to 
patients with suspicious and malignant adnexal masses. With 
appropriate patient selection and proper intra­operative 
technique, our study suggests that laparoscopy may be 
employed in the initial management of many adnexal masses. 
Laparoscopy can be also utilized for surgical staging of early 
ovarian malignancies and in selected patients with advanced 
disease. 
Patients that undergo laparoscopic management of masses 
that are suspicious for malignancy or borderline pathology 
are in increased risk of conversion to laparotomy, blood loss, 
operative time, duration of hospital stay, and postoperative 
complications in comparison to patients with benign masses. 
The preoperative counseling of patients with an adnexal 
mass undergoing laparoscopic resection, should include a 
tailored risk assessment for intraoperative and postoperative 
complications according to the preoperative likelihood of the 
mass being carcinoma or borderline malignancy.
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